✦ LIBER ✦

B171 Polymorphism of TNF-a Predicts Clinical Outcome in Multiple Myeloma Based on Thalidomide Regimens

✍ Scribed by Du, J; Zhang, C; Jiang, H; Yuan, Z; Fu, W; Xiao, H; Hou, J

Book ID: 118629443
Publisher: CIG Media Group, LP.
Year: 2009
Tongue: English
Weight: 95 KB
Volume: 9
Category: Article
ISSN: 1557-9190
DOI: 10.1016/s1557-9190(11)70671-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment outcome of thalidomide based r

Treatment outcome of thalidomide based regimens in newly diagnosed and relapsed/refractory non-transplant multiple myeloma patients: a single center experience from Thailand

✍ Pimjai Niparuck; Ladda Sorakhunpipitkul; Vichai Atichartakarn; Suporn Chuncharun 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 194 KB

The clinical impact and molecular biolog

The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide-based therapy

✍ Kevin D. Boyd; Fiona M. Ross; William J. Tapper; Laura Chiecchio; GianPaolo Dagr 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 1 views

## Abstract Hemizygous deletion of 17p (del(17p)) has been identified as a variable associated with poor prognosis in myeloma, although its impact in the context of thalidomide therapy is not well described. The clinical outcome of 85 myeloma patients with del(17p) treated in a clinical trial incor